Skip to main content
Equibles
EVGN logo

EVGN · Evogene Ltd.

Track EVGN — free

Use EVGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.52 +0.00 (+0.00%)
Rebalance outlook locked
Market Cap
$8.22M
Shares
15.80M

Evogene Ltd. Earnings Call Transcripts

Quarterly earnings calls for Evogene Ltd. (EVGN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-18
Evogene Ltd. (EVGN) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript
Confident tone Forward catalysts and pipeline ChemPass AI platform and differentiation Divestitures and financial position
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Evogene Ltd. (EVGN) Q3 2025 Earnings Call Transcript
Positive tone Divestitures and discontinued operations AgPlenus and agriculture activity Casterra castor seed business
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript
Positive tone Casterra castor seed business Pharma collaborations Asset sales to ICL and cash position
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript
Positive tone Lavie Bio sale to ICL Casterra seed sales and castor oil market Biomica clinical program
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript
Positive tone Revenue growth and Casterra seed sales Subsidiary 2025 targets and milestones AgPlenus collaboration with Bayer
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript
Positive tone AgPlenus Internal Pipeline Biomica BMC128 Clinical Progress Lavie Bio / Yalos Bio-inoculant Commercial Expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Evogene Ltd. (EVGN) Q2 2024 Earnings Call Transcript
Positive tone Production capacity and scaling AgPlenus herbicide pipeline and partnerships Biomica BMC128 clinical results
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Evogene Ltd. (EVGN) Q1 2024 Earnings Call Transcript
Confident tone Subsidiary partnerships with major agritech companies Casterra castor seed supply and ENI orders CPB platform and AI tech-engines
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Evogene Ltd. (EVGN) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Evogene Ltd. (EVGN) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–11 of 11 earnings calls
Key facts CIK 1574565 CUSIP M4119S187 13F (30d) 19 filings 16 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)